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Mutant mice with a hypersensitive serotonin (5-HT)3A receptor were generated through targeted exon replacement. A valine to serine
mutation (V13S) in the channel-lining M2 domain of the 5-HT3A receptor subunit rendered the 5-HT3 receptor70-fold more sensitive
to serotonin and produced constitutive activity when combined with the 5-HT3B subunit. Mice homozygous for the mutant allele (5-
HT3A
vs/vs) had decreased levels of 5-HT3A mRNA. Measurements on sympathetic ganglion cells in these mice showed that whole-cell
serotonin responses were reduced, and that the remaining 5-HT3 receptors were hypersensitive. Male 5-HT3A
vs/vs mice died at 2–3
months of age, and heterozygous (5-HT3A
vs/) males and homozygous mutant females died at 4 – 6 months of age from an obstructive
uropathy. Both male and female 5-HT3A mutant mice had urinary bladder mucosal and smooth muscle hyperplasia and hypertrophy,
whereas male mutant mice had additional prostatic smooth muscle and urethral hyperplasia. 5-HT3A mutant mice had marked voiding
dysfunction characterized by a loss of micturition contractions with overflow incontinence. Detrusor strips from 5-HT3A
vs/vs mice failed
to contract to neurogenic stimulation, despite overall normal responses to a cholinergic agonist, suggestive of altered neuronal signaling
in mutant mouse bladders. Consistent with this hypothesis, decreased nerve fiber immunoreactivity was observed in the urinary bladders
of 5-HT3A
vs/vs compared with 5-HT3A wild-type (5-HT3A
/) mice. These data suggest that persistent activation of the hypersensitive and
constitutively active 5-HT3A receptor in vivo may lead to excitotoxic neuronal cell death and functional changes in the urinary bladder,
resulting in bladder hyperdistension, urinary retention, and overflow incontinence.
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Introduction
The serotonin (5-HT) 3 receptor is unique among the 5-HT re-
ceptor subtypes because it belongs to the family of excitatory
ligand-gated ion channels. Pentamers of 5-HT3A subunits can
form the channel pore, where each subunit has four transmem-
brane domains, the second (M2) of which lines the ion channel
(van Hooft and Yakel, 2003). 5-HT3 receptors can exist function-
ally as either homopentameric channels of the 5-HT3A subunit or
as heteromers with the recently cloned auxiliary 5-HT3B subunit
(Davies et al., 1999). However, because the 5-HT3B subunit alone
cannot produce functional receptors, the 5-HT3A subunit is an
essential component of all serotonin-gated ion channels (Dubin
et al., 1999; Dang et al., 2000).
5-HT3 receptors are expressed in both the peripheral and CNS
and have been implicated in CNS functions such as cognition,
anxiety and emesis, as well as sympathetic, parasympathetic, and
sensory functions in the peripheral nervous system (PNS) (Tecott
et al., 1993; Jackson and Yakel, 1995; Johnson and Heinemann,
1995; Morales and Wang, 2002). 5-HT3 receptors are important
in nociceptive processing (Alhaider et al., 1991; Eide and Hole,
1993; Zeitz et al., 2002), consistent with expression on primary
sensory afferents in the dorsal root ganglion (DRG) and on neu-
rons in the dorsal horn of the spinal cord (Hamon et al., 1989;
Kidd et al., 1993, Tecott et al., 1993; Kia et al., 1995; Morales and
Wang, 2002; Zeitz et al., 2002). 5-HT3 receptors on vagal sensory
afferents modulate visceral afferent and efferent information in
the gastrointestinal tract and cardiovascular system (Leslie et al.,
1990; Merahi et al., 1992; Veelken et al., 1993; Sevoz-Couche et
al., 2003). In the enteric nervous system, 5-HT3 receptors also
regulate gut motility and peristalsis (Galligan, 2002). Within the
lower urinary tract, presynaptic 5-HT3 receptors have been im-
plicated in parasympathetic transmission to the urinary bladder
through neuronal acetylcholine (ACh) release and smooth mus-
cle contraction (Chen, 1990; Barras et al., 1996).
Various mutations in the M2 domain of the 5-HT3A, nicotinic
ACh (nACh), GABAA, and glycine receptors have been shown to
produce hypersensitivity to agonist stimulation. Some of these
mutations occur naturally and are pathologic (Lester and Kar-
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schin, 2000), and knock-in mice carrying hypersensitive nicotinic
receptor mutations have yielded (patho)physiological insights
into nACh receptor function (Lester et al., 2003). To date, there
are no known diseases or animal models linked to point muta-
tions of 5-HT3A receptors. A valine to serine mutation in the M2
domain of the 5-HT3A receptor subunit (V13S) was previously
shown to produce a homomeric receptor 70-fold more sensi-
tive to 5-HT than the wild-type (WT) receptor when expressed in
oocytes (Dang et al., 2000). The purpose of the present study was
to further characterize the hypersensitive V13S mutation in vitro
and to evaluate the V13S mutation as a gain of function alter-
ation in gene knock-in mice.
Coexpression of the mutant 5-HT3A subunit with the wild-
type 5-HT3B subunit resulted in a 5-HT3 receptor that was con-
stitutively active in addition to showing hypersensitivity to 5-HT.
Introduction of the V13S mutation into mice by targeted exon
replacement resulted in expression of 5-HT3A
vs/vs receptors that
were similarly hypersensitive and constitutively active. Unex-
pectedly, 5-HT3A
vs/vs mice died prematurely from complications
related to bladder overactivity, chronic urinary retention, and
urinary tract outlet obstruction. Additional characterization of
the morphologic, pharmacologic, and cystometric changes in the
urinary bladder and urethral outlet tissues of 5-HT3A mutant
mice showed that many of these changes are characteristic of
urinary bladder outlet obstruction (BOO), as seen in patients
with benign prostatic hyperplasia (BPH) or neuropathic lesions
(Turner and Brading, 1997). These data may reflect an important
role of 5-HT3 receptors in lower urinary tract (patho)physiology.
Materials and Methods
Targeted exon replacement of the 5-HT3A receptor. A 6 kb genomic DNA
fragment was cloned from a mouse 129Sv/J genomic library (Stratagene,
La Jolla, CA) that contained exons 6 –9 of the mouse 5-HT3A gene. This
fragment was cloned into the pGEM5-Zf() vector (Promega, Madison,
WI), and the M2 channel domain encoded by exon 7 was mutated to
change the Val13 GTC codon to TCA encoding serine (V13S). Mu-
tagenesis was performed with the Quick-Change mutagenesis kit (Strat-
agene) using the following oligonucleotide and its complement: 5-CTT
CTG GGA TAC TCA TCA (Ser) TTC CTC ATC ATC GTG-3. This
mutation eliminated a native DdeI site (CTNAG) in exon 7, which was
later used for screening the mutation. The targeting vector was generated
by introducing a LoxP-flanked neomycin resistance cassette (Neo),
driven by the phosphoglycerate kinase (PGK) promoter, into a SwaI site
in intron 5 and a PGK-thymidine kinase (TK) cassette into the 3 end of
the genomic clone. A NotI linearized targeting vector was electroporated
into 129Sv/J-derived CJ7 embryonic stem (ES) cells, and homologous
recombinant ES clones were double selected in the presence of 180g/ml
active G418 (Sigma, St. Louis, MO) and 0.2 M 2-fluoro-2-deoxy-1-
D-arabino-furanosyl-5-iodo-uracil (FIAU; Sigma). G418 and FIAU resis-
tant ES clones were identified by PCR using a 5-flanking primer (5F)
upstream of the targeting vector sequence (5-AGC TGC CTT CCT CTG
GAT GCC TAG AGG TCC-3) and a 3 primer (NI) internal to the Neo
cassette (5-GAT CAG CAG CCT CTG TTC CAC ATA CAC TTC ATT
CTC-3). Recombinant ES clones were confirmed by EcoRI Southern
blot analysis using both 5- and 3-flanking region probes. The 5-HT3A
wild-type allele contained a 10 kb EcoRI fragment detected by both the
5- and 3-probes. Incorporation of the Neo cassette introduced an EcoRI
site into the targeted allele, resulting in detection of a 5.5 kb fragment by
the 5-probe and a 7 kb fragment by the 3-probe. Five of 672 ES clones
screened were confirmed as homologous recombinants. The integrity of
the V13S mutation was demonstrated with a PCR assay that amplified a
390 bp amplicon across exons 7– 8 using primers VS1 (5-CCG GAG
GCC TTT ATT CTA CGC AGT CAG CCT C-3) and VS2 (5-CTG GCC
GCT GTA GGT CCT GCT TAT GCA CC-3). To detect the mutation,
the PCR product was further digested with DdeI to generate amplicons of
210 and 140 bp for the mutant and wild-type alleles, respectively
(mutation deleted 1 of 3 DdeI sites in the fragment). The PCR amplicon
was further sequenced with primer VS3 (5-CAG TAT CTT CCT CAT
GGT CGT GG-3). This PCR assay was used as the primary genotyping
assay for 5-HT3A knock-in mice.
ES clones were injected into C57BL/6J embryos, and germline trans-
mission was established by mating chimeras to the C57BL/6J strain. To
minimize the possible effect of the Neo cassette on the expression of the
mutant allele, the Neo gene was deleted from the targeted locus by mating
5-HT3A mutant mice with a transgenic mouse line expressing Cre recom-
binase under the control of a cytomegalovirus promoter-enhancer
(DBA/2tg-2.6; provided as a gift from D. Anderson, Caltech, Pasadena,
CA) (Zinyk et al., 1998). Cre-mediated recombination at the two LoxP
sites flanking the Neo gene resulted in a single LoxP sequence of 34 bp
remaining at the insertion site. Neo-deleted clones were identified by
Southern blot and DNA sequence analysis as described above for ES
clone screening, as well as by PCR across the Neo deletion site. This PCR
assay used primers ND1 (5-AAC TCT AAC AAA GAA ACA TAG AAG
GTT GTT TGG AAG G-3) and ND2 (5-CAA TCA TAG AAC CTT CGA
GCA TAG AAG GTG G-3) and amplified a 334 bp fragment containing
the single LoxP site. All mice used for studies were derived from subse-
quently established heterozygous (5-HT3A
vs/) breeding pairs main-
tained on a mixed genetic background of 129Sv/JC57BL/6JDBA/2.
All animal use procedures were overseen and approved by the Roche Palo
Alto Institutional Animal Care and Use Committee or the Caltech Insti-
tutional Animal Care and Use Committee.
Reverse transcriptase PCR analysis of 5-HT3A transcripts in 5-HT3A
wild-type and mutant mice. Total superior cervical ganglion (SCG) RNA
was isolated using the RNAzol B reagent (Tel-Test,, Friendswood, TX)
according to supplier specifications. RNA samples were diluted 1:100,
and reverse transcriptase (RT)-PCR was performed using 1 l of serial
dilutions of RNA as template in a 25 l reaction using the Thermoscript
One-Step RT-PCR kit (Invitrogen, Rockville, MD). The primers used for
amplification of the 5-HT3A receptor were VS1 and VS2 (described
above), and the primers used for amplification of the 7 nACh receptor
internal control were 7-1 (5-GAT CAC TAT TTG CAG TGG AAC ATG
TCT GAG TAC C-3) and 7-2 (5-CAT GAT CTC AGC CAC AAG CAG
CAT GAA G-3). Both sets of primers were amplified simultaneously in
the PCR to generate amplicons of 300 and 700 bp for the 5-HT3A and 7
nACh receptors, respectively.
Quantitation of mRNA derived from mutant or wild-type alleles was
estimated from the relative representation of the mutant and wild-type
sequences obtained by sequencing the RT-PCR products derived from
5-HT3A
vs/ mice. This approach is based on the premise that although
automatic DNA sequencing signals are highly variable at individual nu-
cleotide positions, these signals retain their relative sizes within a given
stretch of sequence when compared among DNA samples sequenced
under identical conditions. In comparing the relative signals from the
mutation to nearby constant nucleotides between wild-type and mutant
sequences, one can estimate the relative amount of mutant versus wild-
type mRNA in heterozygous mice. After sequencing of the RT-PCR
products from 5-HT3A
/, 5-HT3A
vs/, and 5-HT3A
vs/vs mice using
primer VS3, the area under the wild-type and mutant peaks was normal-
ized to the 3T and 1A nucleotide positions (numbered with respect to the
wild-type V13 codon GTC). The peak area ratios 1G/-3T and 1G/-1A in
5-HT3A
/ RT-PCR products defined pure wild-type sequence, and the
peak area ratios of (1T or 2C or 3A)/(-3T or -1A) in the 5-HT3A
vs/vs
RT-PCR products defined pure mutant sequence. The normalized signal
from 1G (GTC valine codon) was used to estimate the amount of wild-
type sequence (the 5-HT3A
/ sample was defined as 100%). Similarly,
the normalized signals from 1T, 2C, and 3A (TCA serine codon) were
used to estimate the amount of mutant sequence (the 5-HT3A
vs/vs sample
was defined as 100%). Using this approach, average estimates were made
of the amount of mutant and wild-type mRNA expressed in 5-HT3A
vs/
mice.
Xenopus oocyte electrophysiology. As described previously (Dang et al.,
2000), cDNA clones for the mouse 5-HT3A subunit (Maricq et al., 1991)
and for the human 5-HT3B cDNA (Davies et al., 1999) were subcloned
into the oocyte expression vector plasmid pAMV (Nowak et al., 1995).
Mutations in the cDNA were made using the Quick-Change mutagenesis
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kit (Stratagene). Plasmids were linearized with NotI and used as template
to produce mRNA using the T7 mMESSAGE mMACHINE kit (Ambion,
Austin, TX). Stage V-VI Xenopus oocytes were harvested and injected
with 50 nl of cRNA per oocyte (0.5 ng/oocyte). The ratio between the
5-HT3A and the 5-HT3B mRNA was 1:1. Two-electrode voltage-clamp
recordings were performed 24 –36 hr after injection using a Ge-
neClamp500 circuit, a Digidata 1200 digitizer, and pClamp software
(Axon Instruments, Union City, CA). The recording solution contained
(in mM): 96 NaCl, 2 KCl, 2 MgCl2, 5 HEPES, pH 7.4 (ND 96). Whole-cell
current responses to various drug concentrations at indicated holding
potentials (typically 60 mV) were fitted to the Hill equation, I/Imax 
1/[1 (EC50/[A])
n], where I is agonist-induced current at concentration
[A], Imax is the maximum current, EC50 is the concentration inducing
half-maximum response, and n is the Hill coefficient.
Primary cell culture and electrophysiology. SCG neurons were dissected
from 1- to 3-d-old mice and digested in Ca 2, Mg 2-free Hank’s saline
solution containing 0.25% trypsin for 10 min. Cell suspensions were
washed and gently triturated, followed by plating onto culture dishes
precoated with polyornithine and laminin in MEM supplemented with
2% B-27 (Invitrogen), 0.5 mM GlutaMax I (Invitrogen), and 10 ng/ml
nerve growth factor (Sigma). Neurons were studied by patch-clamp re-
cording after 3–10 d in culture. Whole-cell patch-clamp recordings were
performed at room temperature with the following external solution (in
mM): 140 NaCl, 4 KCl, 2 CaCl2, 2 MgCl2, 10 HEPES, pH 7.4. Recording
electrodes had the following intracellular solution (in mM): 140 CsCl, 2
MgCl2, 1.1 EGTA, 0.1 CaCl2, 10 HEPES, pH 7.3. For recording 5-HT-
gated currents, cells were held at80 mV. All patched cells were verified
for their neuronal properties by the presence of voltage-gated sodium
currents. Recordings were performed with an Axopatch 2A amplifier,
Digidata 1200 digitizers, an IBM compatible personal computer, and
pClamp6 or pClamp8 software (Axon Instruments) with standard patch-
clamp protocols. Drugs were delivered through a multi-barrel manifold
with an inner diameter of 250 m.
Histopathology and immunohistochemistry. Complete full-body nec-
ropsies were performed on adult 5-HT3A
/ and 5-HT3A
vs/vs mice, and
histopathology was performed on 40 postmortem tissues covering all
major organ systems. After removal, tissues were immersed in 4% buff-
ered formalin and embedded in paraffin wax. Four micrometer sections
were cut and stained with hematoxylin and eosin (H and E). For whole-
mount immunohistochemical staining of the bladder urothelium (Ga-
bella and Davis, 1998), whole bladders were isolated from euthanized
animals. Isolated bladders were opened by cutting the tissue from the
base to the dome, and the tissue was stretched by pinning it down with
small dissection pins (Watkins, Doncaster, UK) onto balsa wood while
keeping the tissue wet with PBS. The tissue was fixed by immersing the
pinned tissue in 10% buffered formalin at 4°C for 4 hr. After fixation, the
urothelial layer was carefully separated from the underlying smooth
muscle layer under a dissecting microscope. For urothelial whole-mount
staining, the tissue was blocked with PBS containing 20% normal goat
serum and 0.2% Triton X-100 for 2 hr at room temperature. The first
antibody was applied in PBS containing 5% normal goat serum, 0.2%
Triton X-100 overnight at 4°C. A rat Substance P antibody (Accurate
Chemicals, Westbury, NY) was used at a 1:500 dilution, and a rabbit
protein gene product (PGP) 9.5 antibody (Ultraclone, Isle of Wight, UK)
was used at a 1:6000 dilution. The tissue was washed four times for 15
min at room temperature in PBS containing 0.1% BSA and 0.1% Triton
X-100. A secondary cytochrome-3 antibody (Jackson ImmunoResearch,
West Grove, PA) was applied at a concentration of 1:500 for Substance P
staining and 1:300 for PGP 9.5 staining for 4 hr at room temperature in
the same solution. The tissue was washed three times for 10 min in PBS
and mounted with Mounting medium (Polysciences, Warrington, PA).
Immunostaining was analyzed with a Nikon (Tokyo, Japan) Microphot
SA fluorescence microscope, and the observer was blinded to the identity
of the samples when scoring immunoreactivity.
Mouse cystometry. Mice were anesthetized with isoflurane and cystom-
etry was conducted as described previously (Cockayne et al., 2000).
Briefly, the bladder was exposed through a midline abdominal incision. A
saline-filled PE-10 cannula with an enlarged tip was inserted into the
dome of the bladder and secured to the bladder with 5-0 Tevdek suture.
The cannula was tunneled subcutaneously to the back, exteriorized, tied
off, and secured to the skin with 4-0 silk. The muscle layer was closed with
4-0 silk, the skin incision was closed, and the exteriorized part of the
catheter was placed into the subcutaneous space. Mice were returned to
normal caging for 7 d of recovery. For conscious cystometry, each mouse
was placed in a restraint box within a metabolic cage. The bladder can-
nula was exteriorized and connected to a pressure transducer and infu-
sion pump via a three-way connector. Normal saline was infused into the
bladder at a constant rate of 3 ml/hr, and bladder pressure and accumu-
lated void volume was recorded. For carbachol-induced bladder contrac-
tions, carbachol or vehicle was administered intravesically as a 0.1 ml
bolus.
In vitro pharmacology. Isometric smooth muscle contraction was stud-
ied in bladder detrusor strips as described previously (Martin et al.,
2000). Briefly, bladders were removed from mice and dissected into
Krebs’ buffer. Tissues were mounted between two parallel plate elec-
trodes in thermostatically controlled (37°C) organ baths (10 ml) contain-
ing Krebs’ buffer, gassed continuously with 95% O2 and 5% CO2. The
composition of the buffer was (in mM): 118.2 NaCl, 4.6 KCl, 1.6 CaCl2,
1.2 KH2PO4, 1.2 MgSO4, 10 dextrose, 24.8 NaHCO3. The detrusor strips
were equilibrated at a resting tension of 0.5 gm for 1 hr with intermittent
washing, followed by a KCl (67 mM) prime. KCl-induced contractions
were used to normalize the data to control for differences in absolute
contractile values resulting from differences in tissue size or health.
Changes in isometric force were measured by Grass FTO3c transducers
(Grass Instruments, Quincy, MA) and digitized using MacLab data ac-
quisition software (ADInstruments, Colorado Springs, CO). To measure
neurogenic-mediated contraction, a train of square electrical pulses was
applied for 0.5 sec with pulse frequency increasing in twofold increments
(10 V with a pulse width of 0.5 msec). Pulses were delivered by a Grass
S88 stimulator and divided across the tissue baths using a MedLab Sti-
muSplitter (Grass Telefactor, West Warwick, RI). Electrically induced
contractions were confirmed to be neurogenically mediated by their sen-
sitivity to tetrodotoxin (100 nM). Neurogenic contractions were plotted
by fitting a nonlinear equation. In experiments where carbachol was used
to induce contraction, cumulative addition of the drug was applied (van
Rossum, 1963). The potency of carbachol was determined by fitting
mean contractions for each concentration of the drug to the following
equation, which is percentage contraction  [Carbachol] nH/[EC50 
(Carbachol) nH].
Urethral compliance measurements. Biomechanical study of the mouse
urethra was performed as described previously for rats (Jankowski et al.,
2004). Female mice were anesthetized with halothane and catheterized
(PE-10) through the urethra. The catheter contributed to the mainte-
nance of urethral length after excision of the urethra and bladder. Spec-
imens were mounted on an ex vivo testing system (37°C; 95% O2, 5%
CO2). Briefly, the system consisted of a hydrostatic reservoir attached to
a graduated ring stand for controlled application of intralumenal pres-
sure (measured via a strain gauge pressure transducer connected to a
pressure monitor) and a laser micrometer for accurate measurement of
outer diameter. Pressure and diameter data were continuously recorded
via analog-to-digital conversion to a personal computer. Urethral spec-
imens were preconditioned from 0 to 6 mmHg (each pressure held for 10
sec for 10 cycles), followed by pressure increments of 2 mmHg up to 20
mmHg. The experiment was repeated in random order for three posi-
tions along the length of the urethra: proximal (a distance of 30% in vivo
length from proximal end), middle (50% in vivo length from proximal
end), and distal (70% in vivo length from proximal end). Using the
pressure and diameter data recorded, compliance (C) and  stiffness ()
values were calculated for each position:
C 
Dmax  Dmin/Dmin
Pmax  Pmin
,
 
ln PPs
DDs  1
.
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Compliance is a measure of the distensibility of the tissue and provided
the relative change in diameter per unit change in pressure. Pmax and Pmin
represent the maximum and minimum pressures over the pressure range
of interest, and Dmax and Dmin are the respective diameters measured at
these pressures.  stiffness is a parameter that has been widely used to
quantify the nonlinear elastic properties of tubular biological tissue. It
assumes an exponential relationship of the pressure and diameter, with
being the exponent coefficient. Ps is an arbitrary reference pressure taken
here as 10 mmHg, and Ds is the corresponding diameter measured at that
pressure. One-way ANOVA was used for statistical analysis with Stu-
dent–Newman–Keuls post hoc testing.
Results
In vitro characterization of the hypersensitive 5-HT3A V13S
mutation in Xenopus oocytes
We previously used the Xenopus oocyte expression system to
characterize homomeric 5-HT3A receptors containing the V13S
mutation in the M2 channel domain (Dang et al., 2000). The
mutant receptor showed slower activation and desensitization
kinetics (Dang et al., 2000) (Fig. 1A) and was 70-fold more
sensitive to serotonin than the wild-type 5-HT3A receptor (5-
HT3A-WT) (Fig. 1B).
In the present study, we performed oocyte expression studies
to further characterize 5-HT3A receptors containing the V13S
mutation and to predict the functional properties of homozygous
and heterozygous 5-HT3A receptors likely to be expressed in
5-HT3A knock-in mice. Consistent with previous findings, the
homomeric V13S receptor showed higher spontaneous activa-
tion in the absence of agonist, manifested as a slightly increased leak
current under voltage clamp that is blocked by the channel blocker
8-(N,N-diethylamino)-octyl-3,4,5-trimethoxybenzoate (TMB-8;
100 M) (Dang et al., 2000) (Fig. 1C). This spontaneous activity
represents 	10% of the maximal response. We next assessed
heterozygous V13S/5-HT3A-WT pentameric receptors by coin-
jecting a 1:1 mixture of V13S and 5-HT3A-WT cRNAs into oo-
cytes. The V13S/5-HT3A-WT response waveforms desensitized
more slowly than the 5-HT3A-WT receptor and were comparable
with the V13S/V13S waveforms (Fig. 1 A). The V13S/5-
HT3A-WT dose–response relationship was located between the
V13S and 5-HT3A-WT, was shallower than either of the former
two relationships, appeared to consist of at least two components,
and displayed a half-maximal concentration10-fold lower than
the EC50 for the wild-type 5-HT3A receptor (Fig. 1B).
While our efforts in generating the 5-HT3A knock-in mice
were in progress, the human 5-HT3B subunit cDNA was cloned
(Davies et al., 1999), and functional analysis suggested that some
native 5-HT3 receptors are heteromultimers containing at least
the 5-HT3A and 5-HT3B subunits. The 5-HT3B subunit alone
shows no responses to serotonin when expressed in oocytes but
modifies serotonin responses when coexpressed with the 5-HT3A
subunit. Unexpectedly, when V13S 5-HT3A and 5-HT3B subunit
cRNAs were coinjected into oocytes, the resultant receptor
(V13S/5-HT3B) showed high levels of TMB-8-sensitive sponta-
neous activation (Fig. 1D) that was 
50% of the maximal re-
sponse. The waveforms of additional 5-HT3-evoked currents at
V13S/5-HT3B receptors showed more rapid activation and deac-
tivation kinetics than the V13S/V13S or V13S/5-HT3A-WT
waveforms (Fig. 1D). The additional 5-HT3-evoked currents at
the V13S/5-HT3B receptor displayed dose–response relation-
ships with an EC50 of 0.02 nM, resembling those of the V13S
receptor (Fig. 1E). The 5-HT3A-WT/5-HT3B receptor displayed
concentration–response relationships like those of the homo-
meric 5-HT3A-WT receptor, with an EC50 of 2 nM. (Fig. 1E).
Therefore, the most striking effect of these in vitro studies is the
high level of spontaneous activity in the heteromultimeric V13S/
5-HT3B receptor.
Generation of 5-HT3A receptor knock-in mice
The V13S valine to serine mutation in the 5-HT3A receptor was
introduced into the mouse genome by the targeted exon replace-
ment strategy shown in Figure 2. Heterozygous 5-HT3A
vs/ mice
appeared outwardly normal and bred to produce 5-HT3A
/,
5-HT3A
vs/, and 5-HT3A
vs/vs mice. Mice carrying the homozy-
gous V13S knock-in mutation were viable and seemed to de-
velop normally to 2 months of age with no adverse clinical signs
or altered behavior. However, as shown in Table 1, male homozy-
gous mutant mice, and to a lesser extent homozygous females and
heterozygous males and females, died prematurely (Table 1).
Figure 1. Spontaneous and 5-HT-evoked currents from various combinations of 5-HT3A ,
V13S, and 5-HT3B receptor subunits expressed in Xenopus oocytes. A, Representative traces of
normalized currents evoked by 3M 5-HT at60 mV. Traces are shown for 5-HT3A-WT, V13S,
and a 1:1 mixture of 5-HT3-WT and V13S cRNAs. The horizontal bar above the traces represents
the duration of ligand perfusion through the recording chamber. The flat trace at the baseline
level is typical of responses from both the WT and mutant in the presence of 100 nM tropisetron,
a 5-HT3 receptor antagonist. B, Normalized dose–response relationships of oocytes injected
with 5-HT3A-WT (solid squares), V13S (open circles), and a 1:1 mixture of 5-HT3-WT and V13S
(open triangles) cRNAs. C, D, Typical voltage-clamp currents from oocytes injected with V13S
cRNA ( C) or with V13S plus 5-HT3B cRNA 1:1 ( D). Holding potential,60 mV. In each panel,
the top trace shows the response to 100M TMB-8, and the bottom trace shows the response to
0.1M 5-HT. Note the larger leak current at the beginning and end, as well as faster onset and
washout to 0.1 M serotonin in ( D). The TMB-8-sensitive leak current denotes spontaneous
activation of the receptor. E, Normalized dose–response relationships of homomultimeric (5-
HT3A-WT or V13S only; squares) and heteromultimeric (circles) receptors. Receptors included
either the 5-HT3A-WT subunit (solid symbols) or V13S subunit (open symbols).
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Lowered expression of the 5-HT3A receptor mRNA in
5-HT3A
vs/vs mice
Introduction of the V13S mutant receptor into mice would be
expected to produce changes in 5-HT3A receptor function con-
sistent with oocyte expression studies but not to alter mRNA
expression from the V13S mutant allele. To address this directly,
we measured 5-HT3A mRNA expression by RT-PCR using serial
dilutions of total SCG RNA and primers VS1/VS2 for 5-HT3A
receptor mRNA and primers 7-1/7-2 for 7 nACh receptor
mRNA as an internal control (Fig. 3A). RT-PCRs from
5-HT3A
vs/vs mice had more RNA loading than those from
5-HT3A
/ and 5-HT3A
vs/ mice as judged by the relative inten-
sities of the 7 band (Fig. 3A). Despite these RNA loading differ-
ences, 5-HT3A mRNA signals from 5-HT3A
/ and 5-HT3A
vs/
mice showed little difference, whereas in 5-HT3A
vs/vs mice, the
5-HT3A bands were substantially less intense (	25%) compared
with those seen in the other two genotypes.
Reduced expression of 5-HT3A mRNA in homozygous mu-
Figure 2. Strategy for generating 5-HT3A knock-in mice through targeted exon replace-
ment. A, A 6 kb genomic fragment of the mouse 5-HT3A receptor gene (solid bar) was used to
introduce a point mutation (V13S) into exon (open boxes) 7 coding for the M2 domain of the
5-HT3A receptor. The sequence of the mouse 5-HT3A receptor M2 region (positions 1 to 20) is
shown. The Val residue at 13, corresponding to amino acid position 290 in the entire sequence,
is underlined. In the 5-HT3A knock-in mouse this is mutated to Ser (S). Neo and TK selection
markers (hatched boxes) were inserted into the SwaI site (S) in the large intron preceding exon
6 and at the 3 end of the construct, respectively. The Neo sequence was flanked by two LoxP
sites (open arrowheads). The linearized targeting vector was used for transfection of embryonic
stem cells, and the resulting targeted allele was screened as described in Materials and Meth-
ods. B, C, Representative Southern blots of EcoRI (E)-digested genomic DNA were probed with
either a 5-flanking probe ( B) or a 3-flanking probe ( C) to identify the wild-type and mutant
(Mut) alleles. D, 5-HT3A-targeted mice were crossed to Cre-expressing transgenic mice as de-
scribed in Materials and Methods, resulting in a Neo deleted mutant allele with one 34 bp LoxP
site remaining in intron 5. E, F, Representative PCR screening of genomic DNA from Neo-deleted
mice. E, Screening across the mutation site using primers VS1 and VS2 followed by DdeI (D)
digestion. F, Screening across the single LoxP site after removal of the Neo cassette, using
primers ND1 and ND2.
Figure 3. RT-PCR analysis of 5-HT3A mRNA levels in mutant and wild-type mice. A, Dimin-
ished 5-HT3A mRNA levels in the 5-HT3A
vs/vs mice. Total RNA was isolated from the SCG of
5-HT3A
/, 5-HT3A
vs/, and 5-HT3A
vs/vs mice as described in Materials and Methods. Serial
dilutions were prepared as indicated, and 1l of RNA was used as template for RT-PCR analysis
using primers specific for the 5-HT3A receptor (amplicon of300 bp) and the7 nACh receptor
(amplicon of700 bp) as an internal control. Assuming that7 nACh receptor mRNA did not
change, 5-HT3A mRNA was compared with 7 nAChR mRNA at the lowest dilution where
signals could be detected. B, 5-HT3A
vs/mice express comparable levels of the 5-HT3A mutant
and wild-type mRNA. RT-PCR sequencing ( B) of the products shown in A were used to estimate
the relative abundance of wild-type and mutant mRNA in 5-HT3A
vs/ mice as described in
Materials and Methods. The relative abundance of wild-type (solid bars) and mutant (hashed
bars) sequences in the RT-PCR products from 5-HT3A
vs/mice was determined by comparing
the representation of the pure alleles, and the averaged percentage of the products is shown in
the bar graph in C. Oligo, Oligonucleotide.
Table 1. Mortality and mean lifespan of 5-HT3A wild-type and mutant mice
5-HT3A Sex Mortality (dead/total)
Mean lifespan of
dead (d)
/ Male 0/34 (0%)a NA
vs/ Male 42/144 (29%) 185 11
vs/vs Male 33/37 (89%) 71 5
/ Female 0/43 (0%)a NA
vs/ Female 15/113 (13%) 209 24
vs/vs Female 8/43 (19%) 137 23
NA, Not applicable.
aObservations made over a period of400 d.
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tant mice could result from a functional downregulation of con-
stitutively active mutant receptor in all 5-HT3A-expressing neu-
rons, or as a consequence of cell death where the only surviving
neurons are those expressing low levels of the constitutively acti-
vated receptor (Orr-Urtreger et al., 2000). Alternatively, de-
creased levels of 5-HT3A mRNA could be attributable to selective
silencing of the mutant allele because of residual effects of the 34
bp LoxP site remaining in intron 5. To test the latter possibility,
we measured mRNA expression from the mutant and wild-type
alleles by estimating the relative representation of mutant and
wild-type sequences obtained by sequencing the RT-PCR prod-
ucts derived from heterozygous 5-HT3A
vs/mice (Fig. 3A,B) (see
Materials and Methods). 5-HT3A
vs/ mice would be expected to
express both alleles in an unbiased manner and showed only
minor pathology compared with 5-HT3A
vs/vs littermates (de-
scribed below). The RT-PCR sequences shown in Figure 3B were
used to determine the area under the wild-type and mutant peaks
as described in Materials and Methods, and these signals were
used to estimate the amount of wild-type and mutant sequence in
SCG mRNA from 5-HT3A
vs/ mice. The analysis gave average
estimates of 40% wild-type and 45% mutant sequences in SCG
RNA (Fig. 3C), suggesting that the mutant allele is expressed at
nearly equivalent levels to the wild-type allele in heterozygous
5-HT3A
vs/ mice.
Lowered functional expression of the 5-HT3A receptor in 5-
HT3A
vs/vs mice
To examine the functional expression of 5-HT3A receptors, we
performed whole-cell patch-clamp analysis on SCG neurons iso-
lated from 5-HT3A mutant and wild-type mice (Fig. 4, represen-
tative traces shown for each genotype). SCG neurons from
5-HT3A
/ and 5-HT3A
vs/mice responded to 10M 5-HT with
rapidly desensitizing currents that varied between 50 and 400 pA
among individual neurons at a test potential of80 mV (Fig. 4B,
left and middle panels, respectively). The proportion of 5-HT
responsive cells was slightly lower in 5-HT3A
vs/ (10 of 21; 47%)
versus 5-HT3A
/ (9 of 13; 69%) derived neurons. In contrast,
very few neurons from the 5-HT3A
vs/vs mice responded to 5-HT
(3 of 14; 21%), and the few neurons that responded generated
only a 15 pA current to 10 M 5-HT (Fig. 4B, right panel). How-
ever, the 5-HT3A
vs/vs neurons showed nondesensitizing currents,
and responses to 0.1 M 5-HT (Fig. 4A, right panel) were70%
of those seen at 10M (Fig. 4B, right panel). In contrast, 5-HT at
0.3 M failed to activate currents in 5-HT3A
/ or 5-HT3A
vs/
SCG neurons (Fig. 4A, left and middle panels, respectively). The
small responses seen in 5-HT3A
vs/vs neurons displayed both con-
centration dependence and kinetic characteristics predicted from
oocyte expression studies (Fig. 1) and confirm that the 5-HT3A
V13S receptor expressed in vivo is hypersensitive to 5-HT.
Decreased lifespan in 5-HT3A
vs/vs mice resulting from lower
urinary tract dysfunction: pathological evidence
Male homozygous mutant mice died at 2–3 months of age (Table
1). Female homozygous mutant mice, followed by male and fe-
male heterozygous mice, also had a decreased lifespan compared
with 5-HT3A
/mice (Table 1). Moribund 5-HT3A mutant mice
were cachectic and had elevated blood urea nitrogen and protein-
uria. Renal pelvic dilation resulting from urinary tract obstruc-
tion and urinary tract bacterial infections was present, as well as
pyelonephritis and tuberulointerstitial nephritis (Fig. 5, compare
H and G). This was likely the main cause of death in 5-HT3A
vs/vs
mice. Both male and female 5-HT3A
vs/vs mice had hyperdis-
tended urinary bladders characterized by epithelial and detrusor
smooth muscle hyperplasia and hypertrophy (Fig. 5, compare B
and D with A and C). Urinary bladder hypertrophy was evident
by 6 weeks of age in male and female 5-HT3A
vs/vs mice, with
significant increases in urinary bladder weight and twofold to
threefold increases in urinary bladder to body weight ratios (Ta-
ble 2). In addition to changes in the urinary bladder, male
5-HT3A
vs/vs mice also had hyperplasia of prostatic urethral epi-
thelium and surrounding smooth muscle (Fig. 5F) and extensive
suppurative glandular and periglandular inflammatory cell infil-
trate of the prostate and seminal vesicles (Fig. 5, compare F and
E). Proteinaceous plugs were often found in the bladder neck and
proximal urethra of 5-HT3A
vs/vs males. In some mutant mice, we
also observed bone marrow hyperplasia and generalized lym-
phoid atrophy, likely attributed to systemic stress and bacterial
infection.
Pathophysiology associated with lower urinary tract organs in
5-HT3A
vs/vs mice
Urodynamic studies were performed on 5-HT3A
/, 5-HT3A
vs/,
and 5-HT3A
vs/vs mice to determine how histopathological changes
observed in 5-HT3A mutant mice influenced urinary bladder
function. Figure 6 shows representative filling cystometrograms
from conscious mouse cystometry studies in which voiding re-
flexes were measured in response to a continuous intravesical
infusion of saline. In contrast to 5-HT3A
/ mice, where normal
micturition contractions were observed (Fig. 6, top panel; Table
3), 5-HT3 vs/vs mice did not generate voiding contractions (Fig. 6,
bottom panel; Table 3). All 5-HT3A
vs/vs mice studied had a con-
sistent phenotype of overflow incontinence that manifested itself
as constant urine dribbling (Fig. 6; Table 3, c.d.). Heterozygous
mice had an intermediate phenotype that ranged from decreased
void intervals and void volumes to dribbling incontinence (Table
3). Similar cystometric and histopathologic changes were present
in both 8- and 12-week-old mice. In separate experiments where
natural voiding behavior was measured in metabolic chambers,
5-HT3A
vs/vs mice also had a phenotype of constant dribbling and
lacked normal voids compared with 5-HT3A
/ littermate con-
trols (data not shown).
To determine whether detrusor smooth muscle responses
were altered in 5-HT3A mutant mice, we measured neurogenic
contraction of bladder strips from 6-, 8-, and 12-week-old mice
(Fig. 7). Electrical field stimulation of detrusor strips from
Figure 4. Serotonin-induced whole-cell currents from SCG neurons of 5-HT3A
/,
5-HT3A
vs/, and 5-HT3A
vs/vs mice. Whole-cell patch-clamp recordings were obtained from pri-
mary cultures of SCG neurons. Representative voltage-clamped current responses from
5-HT3A
/ (left panel), 5-HT3A
vs/ (middle panel), and 5-HT3A
vs/vs (right panel) mice to low
( A) and high ( B) concentrations of serotonin are shown. The low concentration of serotonin for
5-HT3A
/ and 5-HT3A
vs/ SCG neurons was 0.3M, and that for 5-HT3A
vs/vs neurons was 0.1
M, whereas the high concentration was 10M in all three. The number of 5-HT3A receptors
positive over successfully patched neurons for each genotype is shown below each panel.
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5-HT3A
/mice induced nerve-mediated contractions that were
frequency dependent, whereas bladder strips from 5-HT3A
vs/
and 5-HT3A
vs/vs mice failed to produce isometric contractions in
response to any frequency of stimulus. The loss of neurogenic-
mediated contraction in 5-HT3A
vs/vs and 5-HT3A
vs/ mice may
have been progressive with age, because weak contractions that
were only evident in 6-week-old mice were completely absent at 8
and 12 weeks of age. There were no apparent differences in de-
trusor contraction between male and female wild-type and mu-
tant mice at 6 weeks of age (Fig. 7A). Hence, all remaining in vitro
bladder studies were performed with tissues from males.
We next determined whether intrinsic properties of the detru-
sor smooth muscle were also altered by measuring cholinergic-
mediated contractions in vitro and in vivo (Fig. 8). In 8- and
12-week-old 5-HT3A mutant mice, where there was a complete
loss of neurogenic-mediated contraction (Fig. 7), carbachol-
induced concentration-dependent contractions of the detrusor
smooth muscle in both tissue bath studies in vitro (Fig. 8A,B) and
in conscious cystometry where carbachol was administered intra-
vesically (Fig. 8C,D) after establishment of baseline voiding cys-
tometrograms (Fig. 6). No differences were seen in either study
between wild-type and mutant mice in terms of the efficacy or
potency of carbachol on detrusor smooth muscle responses, ex-
cept at the two highest doses of carbachol in 12-week-old mice in
vivo. Together, these data suggest that the V13S mutation had
little or no overall effect on cholinergic receptor function in the
urinary bladder.
Decreased nerve fiber density in the urinary bladder
urothelium of 5-HT3A knock-in mice
The loss of neurogenic bladder contractions in 5-HT3A mutant
mice could be attributable to changes in the neuronal innervation
of the urinary bladder. 5-HT3 receptors are found on DRG sen-
sory afferents and on parasympathetic efferents innervating the
urinary bladder, and excitotoxic cell death of 5-HT3A V13S-
expressing neurons could lead to a loss of neurons innervating
the lower urinary tract. To address this question, we performed
whole-mount immunostaining of the bladder urothelium from
5-HT3A
/ and 5-HT3A
vs/vs mice using Substance P immunore-
activity as a marker of primary sensory afferents and PGP 9.5
immunoreactivity as a pan-neuronal marker (Navarro et al.,
1997) for all neurons. Consistent with previous observations
(Gabella and Davis, 1998), we detected a greater density of nerve
fiber innervation in the neck of the urinary bladder compared
with the dome in wild-type mice (Fig. 9). In 5-HT3A
vs/vs mice,
staining for both Substance P and PGP 9.5 was markedly de-
creased compared with that seen in 5-HT3A
/ controls. This
observation is consistent with the loss of functional responses of
the detrusor to nerve-mediated stimulation (Fig. 7) and suggests
that a disruption of neuronal networks or connectivity may play
a role in the altered lower urinary tract physiology seen in
5-HT3A
vs/vs mice.
Assessment of urethral compliance in 5-HT3A
vs/vs mice
To determine whether changes in urethral tone contributed to
the overflow incontinence seen in 5-HT3A mutant mice, we mea-
sured the biomechanical properties of urethral compliance and
stiffness. Figure 10 shows low pressure (0 – 6 mmHg)-induced
changes in urethral compliance and stiffness in 5-HT3A
/ and
5-HT3A
vs/vs mice, demonstrating that no differences were ob-
served in either of these measures. As expected for this system
(Jankowski et al., 2004), the proximal urethra was significantly
more compliant than the middle and distal portions when sub-
jected to low-pressure stimulations, and this was similar for both
5-HT3A
/ and 5-HT3A
vs/vs mice (Fig. 10A). Although differ-
ences in  stiffness were not observed between 5-HT3A
/ and
5-HT3A
vs/vs mice for the proximal or middle portions of the ure-
thra, the data did reveal a trend ( p 	 0.1) in which the distal
portion of the urethra in 5-HT3A
vs/vs mice showed less  stiffness
compared with wild-type controls over the entire pressure range
tested (Fig. 10B for 0 – 6 mmHg) (data not shown).
Discussion
In this study, we demonstrated that a V13S gain of function
mutation in the 5-HT3A receptor subunit resulted in a hypersen-
sitive and constitutively active ion channel, and that expression of
this receptor in gene knock-in mice resulted in lower urinary tract
dysfunction with overflow incontinence.
Figure 5. A–H, Histopathology of the lower urinary tract from 5-HT3A
/ ( A, C, E, G) and
5-HT3A
vs/vs ( B, D, F, H ) mice. A, B, Representative photograph of the hyperdistended urinary
bladders seen in 5-HT3A
vs/vs ( B) compared with 5-HT3A
/ ( A) mice. C, D, H and E stained
sections of the urinary bladder wall highlighting the lumen (L), urothelial mucosal layer (U), and
the detrusor smooth muscle layer (DSM). E, F, H and E stained sections of the prostatic urethra
and surrounding prostatic tissue. Note the increased thickness of the urinary bladder wall (D vs
C) and prostatic urethra (arrow in F vs E) in 5-HT3A
vs/vs compared with 5-HT3A
/mice, with
associated mucosal hyperplasia and smooth muscle hypertrophy. In addition, extensive glan-
dular and periglandular inflammatory cell infiltrate can be seen in the prostatic sections of male
5-HT3A
vs/vs mice ( F). G, H, Longitudinal sections of kidney from 5-HT3A
/ ( G) and 5-HT3A
vs/vs
( H ) mice showing the markedly distended renal pelvis in 5-HT3A mutant mice as a consequence
of chronic lower urinary tract obstruction. Scale bars: C, D, 50m; E–H, 100m.
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Previous studies demonstrated that the V13S mutation in the
A subunit of the 5-HT3 receptor rendered the receptor hypersen-
sitive to 5-HT (Dang et al., 2000). These findings have been ex-
tended to show that coexpression of the V13S 5-HT3A subunit
with the wild-type 5-HT3B subunit (Davies et al., 1999) resulted
in a constitutively active V13S/5-HT3B heteromultimeric recep-
tor with 5-HT potency similar to that of the homomeric V13S
receptor. Because 5-HT3 subunits can form homomeric 5-HT3A
and heteromeric 5-HT3A/B receptors but not homomeric 5-HT3B
receptors (Davies et al., 1999), it is proposed that nearly all func-
tional 5-HT3 receptors in the PNS and CNS of 5-HT3A
vs/vs mice
are hypersensitive to 5-HT and constitutively active. Constitutive
activity of a cation-selective excitatory channel could lead to ei-
ther functional desensitization of the receptor or neuron (as pro-
duced by capsaicin on c-fiber sensory afferents), or to persistent
neuronal hyperexcitability followed by excitotoxic cell death. In
support of the latter hypothesis, SCG neurons from 5-HT3A
vs/vs
mice had decreased levels of 5-HT3 mRNA, showed marked def-
icits in 5-HT-elicited whole-cell currents, and the few neurons
that did respond to 5-HT displayed significant increases in 5-HT
potency. Although we have no direct evidence for constitutively
active 5-HT3 receptors in neurons of knock-in mice, these data
are consistent with the idea that 5-HT3A
vs/vs mice expressed a gain
of function mutation with a high level of constitutive activity,
leading to neurotoxic cell death, and low levels of a hypersensitive
receptor in the remaining 5-HT3A-positive neurons.
Phenotypic characterization of 5-HT3A mutant mice revealed
that both males and females developed severe lower urinary tract
dysfunction characterized by enlarged urinary bladders with hy-
perplasia and hypertrophy of the epithelium and detrusor
smooth muscle. These bladders showed loss of responsiveness to
neurogenic stimulation with little or no change in responsiveness
to an exogenous muscarinic agonist, decreased urinary bladder
innervation, and a complete loss of micturition contractions with
constant urine leakage and overflow incontinence. In addition to
changes in the urinary bladder, male 5-HT3A
vs/vs mice had hyper-
plasia of prostatic urethral epithelium and surrounding smooth
muscle, with inflammatory cell infiltrate of the prostate and sem-
inal vesicles. The main cause of death in 5-HT3 mutant mice was
likely urinary tract bacterial infection and renal failure resulting
from chronic urinary retention and urinary tract obstruction.
5-HT3A
vs/vs males died more prematurely than females, suggest-
ing that changes in the prostate and surrounding tissues may have
exacerbated a common underlying pathology present in both
sexes, possibly by creating a greater degree of outlet obstruction.
The effect of the V13S mutation was also highly penetrant in that
heterozygotes showed a loss of responsiveness to neurogenic
stimulation and an average lifespan between that of homozygous
mutants and wild-type controls. Despite the well described role
for 5-HT3 receptors in gastrointestinal, cardiovascular, and CNS
functions, we did not observe histopathological changes or overt
behavioral signs of dysfunction in these physiological systems in
5-HT3A
vs/vs mice. Future studies exploring these physiological
pathways would be of interest.
Many of the morphological and functional changes in the
urinary bladders of 5-HT3A
vs/vs mice are similar to the changes
described for animals or humans with urinary bladder outlet
obstruction or neuropathic lesions (Turner and Brading, 1997;
Bassuk et al., 2000; Pandita et al., 2000). This raises the question
of whether 5-HT3A
vs/vs mice offer a genetic model for bladder
instability associated with partial outlet obstruction or changes in
the neuronal control of micturition as seen in neuropathic dis-
ease. Partial outlet obstruction in surgically obstructed animals
or secondary to BPH is often associated with bladder hypertro-
phy, detrusor instability, and urinary retention (Hines, 1996;
Turner and Brading, 1997). Adaptive changes in the bladder can
also occur in response to changes in innervation, and partial de-
nervation of the detrusor has been associated with bladder insta-
bility in outflow obstruction, neuropathic disease, and idiopathic
Table 2. Urinary bladder and body weights of 5-HT3A wild-type and mutant mice
Age Sex 5-HT3A Bladder weight (gm) Body weight (gm) Bladder/body weight Fold change
d
6 weeks Male / 0.03 0.0 25.65 0.91 1.16103
Male vs/vs 0.04 0.0 24.61 1.12 1.62103 1.4
Female / 0.02 0.0 17.60 0.23 1.21103
Female vs/vs 0.05 0.0a 19.51 1.02 2.41103
a
2.0
8 weeks Male / 0.03 0.0 25.66 0.98 1.33103
Male vs/vs 0.09 0.0b 26.07 1.07 3.74103
c
2.8
Female / 0.03 0.0 21.03 0.45 1.27103
Female vs/vs 0.07 0.0a 21.44 1.30 3.46103
a
2.7
ap	 0.05.
bp 0.056.
cp 0.062; unpaired t test comparing 5-HT3A
/ and 5-HT3A
vs/vs mice.
dFold change in bladder/body weight ratios between 5-HT3A
/ and 5-HT3A
vs/vs mice.
Figure 6. Open-filling cystometry in 5-HT3A
/ and 5-HT3A
vs/vs mice. Representative cys-
tometrograms from conscious 8-week-old male 5-HT3A
/ (top panel) and 5-HT3A
vs/vs (bot-
tom panel) mice. Traces illustrate bladder pressure (BP) recorded in response to a constant
infusion of saline and accumulated void volumes (VV) recorded with each micturition. Micturi-
tion voiding contractions (arrows) were observed in 5-HT3A
/mice. In contrast, 5-HT3A
vs/vs
mice had a complete loss of micturition contractions, consistent with a phenotype of dribbling
overflow incontinence.
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instability (Turner and Brading, 1997; Lluel et al., 1998; Charlton
et al., 1999; Mills et al. 2000; Pandita et al., 2000). Denervation of
the detrusor has been most widely associated with loss of post-
ganglionic parasympathetic nerves, and it has been suggested that
these areas of patchy denervation are responsible for both de-
creased nerve-evoked contractility and increased excitability
contributing to bladder instability (Levin et al., 1995; Turner and
Brading, 1997). Decreased innervation and loss of nerve-evoked
bladder contractility, together with bladder hypertrophy and
overflow incontinence, is consistent with an outlet obstruction phe-
notype in 5-HT3A
vs/vs mice. The current data would suggest that
persistent activation of 5-HT3A receptors, and excitotoxic neuronal
cell loss, played a principal role in the development of denervation-
induced changes in the urinary bladder of these mice.
The localization of 5-HT3 receptors in the dorsal horn of the
spinal cord and in peripheral sensory ganglia (Tecott et al., 1993;
Johnson and Heinemann, 1995; Kia et al., 1995; Morales and
Wang, 2002) suggests that excitotoxic cell death could affect sen-
sory afferent neurons innervating the urinary bladder of
5-HT3A
vs/vs mice. In the DRG, 5-HT3 receptors are expressed by
myelinated A afferents and a small population of unmyelinated
Table 3. Conscious open-filling cystometry parameters in 5-HT3A wild-type and mutant mice
5-HT3A Sex Age (weeks) Void pressure (mmHg) Void interval (min) Void volume (ml) Overflow incontinence
a
/ Male 8 73.3 22.1 8.0 2.6 0.31 0.08 1(4)
vs/ Male 8 c.d. c.d. c.d. 3(3)
vs/vs Male 8 c.d. c.d. c.d. 3(3)
/ Female 8 42.7 8.2 10.5 3.4 0.24 0.07 0(4)
vs/ Female 8 31.0 3.5 6.1 1.1 0.15 0.03 1(4)
vs/vs Female 8 c.d. c.d. c.d. 4(4)
/ Male 12 61.0 8.1 5.4 0.5 0.23 0.02 0(6)
vs/ Male 12 41.7 6.8 7.2 0.4 0.30 0.06 2(5)
vs/vs Male 12 c.d. c.d. c.d. 6(6)
/ Female 12 50.7 6.3 6.5 1.4 0.24 0.06 0(6)
vs/ Female 12 39.7 4.9 4.2 0.5 0.15 0.04 0(3)
vs/vs Female 12 c.d. c.d. c.d. 7(8)
c.d., Constant dribblers.
aFor each group of mice, the number of overflow incontinent animals is shown against the total number of animals per group (in parentheses).
Figure 7. Neurogenic-mediated contractions of detrusor smooth muscle from 5-HT3A
/,
5-HT3A
vs/, and 5-HT3A
vs/vs mice of various ages. A, Detrusor strips from male and female
6-week-old 5-HT3A
/ mice (closed squares and closed circles) responded to electrical field
stimulation, whereas bladder strips from male and female 6-week-old 5-HT3A
vs/vs mice (open
squares and open circles) showed minimal responses to neurogenic-mediated contraction. B, C,
At 8 ( B) and 12 ( C) weeks of age, neurogenic-mediated contractions were completely absent in
detrusor strips from male 5-HT3A
vs/ and 5-HT3A
vs/vs mice (closed circles and open squares),
whereas male 5-HT3A
/mice responded to electrical field stimulation (closed squares). Con-
tractile responses were plotted as a percentage of KCl (67 mM)-induced maximal force. Points
represent mean contraction SEM for n 3– 4 animals per group.
Figure 8. Effect of carbachol on detrusor smooth muscle contraction in male 5-HT3A
/,
5-HT3A
vs/, and 5-HT3A
vs/vs mice. A, B, Carbachol induced concentration-dependent contrac-
tions of bladder smooth muscle in vitro in both 8-week-old ( A) and 12-week-old ( B)
5-HT3A
/ (closed squares), 5-HT3A
vs/ (closed circles), and 5-HT3A
vs/vs (open squares) mice.
C, D, In conscious open filling cystometry, carbachol induced concentration-dependent in-
creases in bladder pressure (BP) in 8-week-old ( C) and 12-week-old ( D) 5-HT3A
/,
5-HT3A
vs/, and 5-HT3A
vs/vs mice (symbols as above). In both experiments, no differences were
seen in carbachol-induced contractions between wild-type and mutant mice, except at the data
points indicated (*). Contraction and bladder pressure changes were plotted as a percentage of
KCl (67 mM)-induced maximal force ( A, B) and increases from baseline bladder pressure (C, D),
respectively. Points represent mean  SEM for n  3– 6 animals per group. *p 	 0.05,
statistical significance versus 5-HT3A
/mice.
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C-fibers, which overlap with traditional peptidergic and nonpep-
tidergic subpopulations (Zeitz et al., 2002). Persistent activation
and partial ablation of primary sensory afferents is consistent
with the decreased density of Substance P immunoreactive nerve
fibers in the bladders of 5-HT3A
vs/vs mice. A and C-fiber affer-
ents are important in reflex-voiding pathways in the urinary
bladder (Yoshimura and de Groat, 1997), and the loss of 5-HT3A-
expressing afferents could lead to decreased urinary bladder re-
flexes and compensatory bladder hypertrophy. 5-HT3 receptors
are also expressed on many spinal cord neurons, and these recep-
tors have been shown to modulate primary afferent transmission.
Spinal 5-HT3 receptors can either facilitate or inhibit nociceptive
processing, the latter via activation of GABAergic inhibitory in-
terneurons (Alhaider et al., 1991; Zeitz et al., 2002). Thus, the loss
of 5-HT3-expressing neurons in the CNS might indirectly influ-
ence afferent input to the urinary bladder.
5-HT receptors on parasympathetic efferent nerves also mod-
ulate detrusor smooth muscle contraction (Barras et al., 1996;
Sellers et al., 2000), and evidence supports a role for 5-HT3 recep-
tors in the lower urinary tract. In the rabbit, for example, excita-
tory effects of 5-HT on the detrusor smooth muscle have been
attributed to presynaptic 5-HT3 receptors on parasympathetic
efferents (Chen, 1990; Barras et al., 1996). Interestingly, in a rab-
bit model of BOO, an increased density of 3[H]-5-HT-binding
sites was observed in the detrusor smooth muscle (Khan et al.,
1999), although the receptor subtype responsible for 5-HT bind-
ing was not characterized. Detrusor instability in rabbit BOO
models is also associated with partial denervation and cholinergic
supersensitivity (Speakman et al., 1987; Rohrmann et al., 1997).
It is possible that in 5-HT3A mutant mice, hypersensitive and
constitutively active 5-HT3A receptors on parasympathetic nerve
fibers innervating the urinary bladder contributed to excitatory
responses in the detrusor, with eventual neurotoxic cell death.
5-HT3A
vs/vs mice did show a slight age-related loss of neurogenic
bladder contractions and a decreased density of PGP 9.5 immu-
noreactive nerve fibers innervating the bladder. This latter obser-
vation is consistent with the findings in a recently described
model of murine outlet obstruction, where bladder hypertrophy
and overactivity were associated with decreased PGP 9.5, nitric
oxide synthase, and vesicular ACh transporter immunoreactive
nerve terminals in the detrusor smooth muscle (Pandita et al.,
2000).
Based on our current data, it remains uncertain whether
changes in the urethra contributed to the obstructive pathology
seen in 5-HT3A
vs/vs mice. Although no changes were observed in
urethral biomechanical properties between 5-HT3A
/ and
5-HT3A
vs/vs mice, we cannot rule out the possibility of alterations
in physiological pathways not measured by this approach, such as
the modulation of urethral smooth muscle relaxation by nitric
oxide. Constitutive activation of 5-HT3A receptors could also
have caused obstruction in other outlet organs such as the blad-
der neck. Inflammation and hyperplasia of the prostatic urethra
in male 5-HT3
vs/vs mice was also a probable contributor to blad-
der outlet obstruction, and this is consistent with the exacerbated
disease process observed in male versus female mutant mice.
In summary, our findings suggest a role for 5-HT3 receptors in
the development of an outlet obstructive pathology associated
with bladder instability and overflow incontinence and provide
the first report associating a hypersensitive gain of function mu-
tation in the 5-HT3 receptor with a neuro-urological pathology.
The phenotype of this strain contrasts with that of 5-HT3A recep-
tor null mice (Zeitz et al., 2002), which display reduced tissue
injury-induced persistent nociception but no obvious urinary
tract malfunction. These findings emphasize that complemen-
tary information can be obtained from gain of function and loss
of function genetic manipulations (Lester et al., 2003). The
knock-in approach for studying gain of function mutations has
been described previously for nACh receptors, where point mu-
tations in the M2 domain of the 7 (Orr-Urtreger et al., 2000;
Broide et al., 2002) and 4 (Labarca et al., 2001) nACh receptor
subunits resulted in hypersensitivity to both acetylcholine and
nicotine in oocytes in vitro. Similar to 5-HT3A
vs/vs mice, expres-
sion of hypersensitive 4 and 7 nACh receptors in vivo resulted
in reduced levels of receptor subunit protein levels, neuronal cell
death, and phenotypic behavioral changes (Labarca et al., 2001;
Figure 9. Decreased innervation density in the bladder urothelium of 5-HT3A
vs/vs mice. A–H,
Representative images of whole-mount bladder immunostaining from 8- to 10-week-old
5-HT3A
/ ( A, C, E, G) and 5-HT3A
vs/vs ( B, D, F, H ) mice (n3) for Substance P (A–D, green)
and PGP 9.5 (E–H, red). Note the decreased density of the fine nerve fibers coursing through the
urothelium in both the dome ( A, B, E, F ) and the neck (C, D, G, H ) regions of the urinary
bladder. Scale bar: A–H, 50m.
Figure 10. Urethral compliance and-stiffness measurements in female 5-HT3A
/ and
5-HT3A
vs/vs mice. A, B, Data shown represent low pressure (0 – 6 mmHg)-induced changes in
the compliance ( A) and  stiffness ( B) of the proximal (prox), middle (mid), and distal (dist)
urethra in 5-HT3A
/ (closed bars) and 5-HT3A
vs/vs (open bars) mice. Data represent the
mean SEM for n 4 –5 animals per group. **p	 0.01, statistically significant difference in
the compliance of the proximal urethra compared with the middle and distal portions in both
5-HT3A
/ and 5-HT3A
vs/vs mice.
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Broide et al., 2002). Interestingly, previous studies have also
shown that knock-out mice lacking either the 3 subunit or both
the 2 and 4 subunits of the nACh receptor had profoundly
enlarged bladders with overflow incontinence, and developed
urinary tract infections and bladder stones (Xu et al., 1999a; Xu et
al., 1999b). Taken together, these data may help us to better un-
derstand the role of ligand-gated ion channels such as the 5-HT3
and nACh receptors in the neurophysiologic control of the blad-
der and the lower urinary tract.
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